Free Trial

Itonic (ITOC) Competitors

$0.36 +0.02 (+6.47%)
As of 10:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ITOC vs. CTSO, MODD, POAI, RVP, and LFWD

Should you buy Itonic stock or one of its competitors? MarketBeat compares Itonic with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Itonic include Cytosorbents (CTSO), Modular Medical (MODD), Predictive Oncology (POAI), Retractable Technologies (RVP), and Lifeward (LFWD). These companies are all part of the "medical equipment" industry.

How does Itonic compare to Cytosorbents?

Itonic (NASDAQ:ITOC) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

In the previous week, Itonic had 6 more articles in the media than Cytosorbents. MarketBeat recorded 7 mentions for Itonic and 1 mentions for Cytosorbents. Cytosorbents' average media sentiment score of 1.87 beat Itonic's score of 0.41 indicating that Cytosorbents is being referred to more favorably in the news media.

Company Overall Sentiment
Itonic Neutral
Cytosorbents Very Positive

32.9% of Cytosorbents shares are held by institutional investors. 6.6% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Itonic has a net margin of 0.00% compared to Cytosorbents' net margin of -31.85%. Itonic's return on equity of 0.00% beat Cytosorbents' return on equity.

Company Net Margins Return on Equity Return on Assets
ItonicN/A N/A N/A
Cytosorbents -31.85%-235.57%-37.88%

Itonic has higher earnings, but lower revenue than Cytosorbents.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Itonic$520K11.87-$5.10MN/AN/A
Cytosorbents$37.06M0.68-$8.20M-$0.19N/A

Cytosorbents has a consensus price target of $5.38, suggesting a potential upside of 1,233.75%. Given Cytosorbents' stronger consensus rating and higher probable upside, analysts plainly believe Cytosorbents is more favorable than Itonic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cytosorbents
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Itonic has a beta of 2.79, indicating that its stock price is 179% more volatile than the broader market. Comparatively, Cytosorbents has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

Summary

Itonic and Cytosorbents tied by winning 7 of the 14 factors compared between the two stocks.

How does Itonic compare to Modular Medical?

Itonic (NASDAQ:ITOC) and Modular Medical (NASDAQ:MODD) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

In the previous week, Itonic had 6 more articles in the media than Modular Medical. MarketBeat recorded 7 mentions for Itonic and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.89 beat Itonic's score of 0.41 indicating that Modular Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Itonic Neutral
Modular Medical Very Positive

Itonic has higher revenue and earnings than Modular Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Itonic$520K11.87-$5.10MN/AN/A
Modular MedicalN/AN/A-$18.82M-$14.71N/A

Itonic's return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ItonicN/A N/A N/A
Modular Medical N/A -245.85%-190.80%

27.5% of Modular Medical shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Itonic has a beta of 2.79, meaning that its share price is 179% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Itonic beats Modular Medical on 6 of the 9 factors compared between the two stocks.

How does Itonic compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and Itonic (NASDAQ:ITOC) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Itonic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Predictive Oncology has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, Itonic has a beta of 2.79, meaning that its share price is 179% more volatile than the broader market.

In the previous week, Itonic had 7 more articles in the media than Predictive Oncology. MarketBeat recorded 7 mentions for Itonic and 0 mentions for Predictive Oncology. Itonic's average media sentiment score of 0.41 beat Predictive Oncology's score of 0.00 indicating that Itonic is being referred to more favorably in the news media.

Company Overall Sentiment
Predictive Oncology Neutral
Itonic Neutral

Itonic has lower revenue, but higher earnings than Predictive Oncology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Predictive Oncology$1.66M14.50-$12.66M-$13.50N/A
Itonic$520K11.87-$5.10MN/AN/A

Itonic has a net margin of 0.00% compared to Predictive Oncology's net margin of -5,065.23%. Itonic's return on equity of 0.00% beat Predictive Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
Predictive Oncology-5,065.23% -732.73% -235.55%
Itonic N/A N/A N/A

9.0% of Predictive Oncology shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Itonic beats Predictive Oncology on 7 of the 11 factors compared between the two stocks.

How does Itonic compare to Retractable Technologies?

Itonic (NASDAQ:ITOC) and Retractable Technologies (NYSE:RVP) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Itonic has a beta of 2.79, indicating that its share price is 179% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

In the previous week, Itonic had 7 more articles in the media than Retractable Technologies. MarketBeat recorded 7 mentions for Itonic and 0 mentions for Retractable Technologies. Itonic's average media sentiment score of 0.41 beat Retractable Technologies' score of 0.00 indicating that Itonic is being referred to more favorably in the media.

Company Overall Sentiment
Itonic Neutral
Retractable Technologies Neutral

Itonic has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Itonic's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
ItonicN/A N/A N/A
Retractable Technologies -41.11%-17.15%-9.33%

7.6% of Retractable Technologies shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Itonic has higher earnings, but lower revenue than Retractable Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Itonic$520K11.87-$5.10MN/AN/A
Retractable Technologies$37.15M0.56-$7.01M-$0.21N/A

Summary

Itonic beats Retractable Technologies on 9 of the 12 factors compared between the two stocks.

How does Itonic compare to Lifeward?

Itonic (NASDAQ:ITOC) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

26.8% of Lifeward shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Itonic had 5 more articles in the media than Lifeward. MarketBeat recorded 7 mentions for Itonic and 2 mentions for Lifeward. Lifeward's average media sentiment score of 1.33 beat Itonic's score of 0.41 indicating that Lifeward is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Itonic
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Lifeward
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Itonic has higher earnings, but lower revenue than Lifeward.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Itonic$520K11.87-$5.10MN/AN/A
Lifeward$22.03M0.89-$19.91M-$19.66N/A

Lifeward has a consensus target price of $10.00, indicating a potential upside of 42.53%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Itonic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Lifeward
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67

Itonic has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Itonic's return on equity of 0.00% beat Lifeward's return on equity.

Company Net Margins Return on Equity Return on Assets
ItonicN/A N/A N/A
Lifeward -123.66%-243.14%-97.39%

Itonic has a beta of 2.79, indicating that its share price is 179% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market.

Summary

Itonic and Lifeward tied by winning 7 of the 14 factors compared between the two stocks.

Get Itonic News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITOC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITOC vs. The Competition

MetricItonicSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ Exchange
Market Cap$6.17M$2.82B$4.35B$12.31B
Dividend YieldN/AN/A10.25%5.66%
P/E RatioN/A13.7222.3324.76
Price / Sales11.8763.86130.36168.32
Price / CashN/A8.0340.1937.92
Price / Book0.755.8327.526.90
Net Income-$5.10M$7.39M$116.61M$337.45M
7 Day Performance-28.42%-1.69%2.54%2.84%
1 Month Performance19.08%-1.53%2.67%4.78%
1 Year PerformanceN/A12.97%15.22%33.08%

Itonic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITOC
Itonic
0.8271 of 5 stars
$0.36
+6.5%
N/AN/A$6.17M$520KN/AN/A
CTSO
Cytosorbents
2.0998 of 5 stars
$0.38
-7.5%
$5.38
+1,314.5%
-63.3%$23.86M$37.06MN/A220
MODD
Modular Medical
0.9342 of 5 stars
$4.85
+3.9%
N/A-79.4%$22.61MN/AN/A20
POAI
Predictive Oncology
N/A$6.62
-2.2%
N/A-50.6%$22.47M$1.66MN/A30
RVP
Retractable Technologies
N/A$0.69
+0.4%
N/A+7.5%$20.75M$37.15MN/A240

Related Companies and Tools


This page (NASDAQ:ITOC) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners